Goldman Sachs Group Inc Takeda Pharmaceutical CO LTD Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,953,331 shares of TAK stock, worth $70.8 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,953,331
Previous 4,500,965
10.05%
Holding current value
$70.8 Million
Previous $69.6 Million
4.21%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding TAK
# of Institutions
385Shares Held
80.6MCall Options Held
1.7MPut Options Held
276K-
Capital Research Global Investors Los Angeles, CA13.4MShares$192 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.69MShares$110 Million0.01% of portfolio
-
Ubs Group Ag5.89MShares$84.2 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.93MShares$56.2 Million0.48% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.86MShares$55.2 Million0.08% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.4B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...